Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Lightpath Technologies Sells China Unit for $4.5M

Lightpath Technologies has agreed to sell its China subsidiary, LightPath (Zhenjiang) Optical Instrumentation Co., Ltd., for $4.5 million, with payment spread over five years after closing. The deal includes the company’s manufacturing facility and all China operations.

The transaction is expected to close in the coming weeks. Once it does, Lightpath said it will have no facilities or operations in China.

The company said the China business generated an average of about $4.5 million in annual revenue from third-party customers in fiscal 2025 and fiscal 2026, based on preliminary figures. That revenue will drop out of consolidated results after the sale closes.

Lightpath said the buyer, which is owned by members of the facility’s incumbent management team, will continue supplying products to Lightpath as a third-party vendor for commercial customers in the U.S. and Europe.

The company described the divestiture as the final step in its shift to a fully western-aligned manufacturing footprint. It said the move leaves its primary manufacturing base in Orlando, Florida, with additional facilities in Texas, New Hampshire, and Latvia. As a result of these announcements, the company's shares have moved 3.96% on the market, and are now trading at a price of $12.61. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS